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httpcense.Abstract Background: Bronchial asthma (BA) is a common chronic inﬂammatory condition
affecting the airways. Bronchial asthma not only affects the lung but also affects other organs
including the heart. Right ventricular (RV) hypertrophy and dilation and left ventricular (LV) dia-
stolic dysfunction were observed in severe BA. However, evaluation of ventricular function in this
disease by the use of recently proposed Doppler echocardiographic methods has not been exten-
sively studied before.
Purpose: Theaimof this studywas toevaluate ventricular function inyoungadult patientswithBA.
Patients and methods: Fifty patients with bronchial asthma and 30 control subjects (mean ages
28.3 ± 7.0and26.8 ± 6.2 years, respectively) participated in this study.Systolic functionwasassessed
by subjective evaluation ofwallmotion for both ventricles andby fractional shortening for the left ven-
tricle (LV). LV diastolic function was evaluated by standard pulsed-waveDoppler echocardiography,
myocardial performance index (MPI) and transmitral ﬂowpropagation velocity (TFPV).RV function
was evaluated by MPI. No subject had signs or symptoms of clinically overt heart failure.
Results: Our results revealed that there were statistically signiﬁcant differences in the peakE veloc-
ity, peak E velocity/peak A velocity ratio and isovolumetric relaxation time between the two groups
(p< 0.05). Mean LVMPI in the bronchial asthma group (0.40 ± 0.13) was also signiﬁcantly higher
than that of the controls (0.36 ± 0.11, p< 0.05). On the other hand, there were no signiﬁcant differ-ayah National Hospital, Kha-
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28 M.E. Abdalla, H.A.E. Azeemences in the mean value of peak A velocity, deceleration time and isovolumetric contraction time
between bronchial asthma patients and controls. TFPV was signiﬁcantly reduced in the bronchial
asthma group when compared to controls (37.10 ± 2.13 versus 43.40 ± 3.11, respectively,
p= 0.001).Weobservedno signiﬁcant difference in the echocardiographic indices ofRVperformance
between the two groups. The mean RVMPI in the bronchial asthma group (0.29 ± 0.11) was not sig-
niﬁcantly different from that of the controls (0.27 ± 0.08).
Conclusion: From this study we concluded that LV diastolic function is impaired in patients with
bronchial asthma despite no effect on RV diastolic function.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Asthma is a chronic inﬂammatory disorder of the airways
characterized by an obstruction of airﬂow, which may be com-
pletely or partially reversed with or without speciﬁc therapy
[1]. Dramatic worldwide variations in asthma prevalence have
been found with the highest rates in the United Kingdom, Aus-
tralia, and New Zealand, and the lowest prevalence in Eastern
Europe, China, and India [2–4]. Bronchial asthma not only af-
fects the lung but also affects other organs including the heart.
Echocardiography detected RV systolic and diastolic dysfunc-
tions in a considerable percent of asthmatic children even with
mild cases. Left ventricular dysfunction is usually detected in
severe asthmatic cases. However, these cardiac dysfunctions
may be reversible especially in acute cases [5,6].
In bronchial asthma recurrent exposure to hypoxemia is
one of the mechanisms besides others leading to sustained pul-
monary vasoconstriction and narrowing of the pulmonary vas-
culature. Consequently, pulmonary hypertension develops
leading to right heart enlargement with ventricular hypertro-
phy, and impaired cardiac function, known as cor pulmonale
[7]. The occurrence of supraventricular tachycardia in BA is re-
lated to the presence of interventricular septal hypertrophy,
LV dysfunction, and increased pulmonary artery pressure
(PAP) [8]. Asthmatic medications can also affect the echocar-
diographic ﬁndings. Chronic administration of theophylline
may cause a slight increase in percent fractional shortening,
outﬂow peak velocity and atrial contribution to ventricular ﬁll-
ing in the asthmatic children as compared to normal though
these ﬁndings were found to be insigniﬁcant [9].
Although there are many noninvasive diagnostic modalities
of ventricular function, right ventricular function remains dif-
ﬁcult and challenging to quantify. Conventional imaging tech-
niques such as radionuclide ventriculography and standard
echocardiography have limitations when applied to the right
ventricle. Radionuclide ventriculography involves exposure
to radiation, is relatively expensive, has restricted availability,
and is not easily repeatable [10].
Recently myocardial performance index (MPI) and transmi-
tral ﬂow propagation velocity (TFPV) have been suggested for
the evaluation of ventricular function. MPI is calculated from
the pulsed Doppler recordings of ventricular inlet and outlet
velocities and thus combines both systolic and diastolic ventric-
ular performances. It reﬂects global ventricular function and is
less affected by localized wall motion abnormalities. It has been
shown to be independent of changes in preload and afterload in
the assessment of RVmyocardial performance [11,12]. TFPV is
obtained from color Doppler M-mode echocardiography and isused to assess LV diastolic function. This technique has been
shown to be relatively independent of preload in patients with
hypertrophic cardiomyopathy [13], dilated cardiomyopathy
[14,15] and pulmonary hypertension [16,17].
In a study done by Garcia et al., the Peak E velocity/TFPV
ratio was found the best estimate of pulmonary wedge pressure
[18]. In a more recent study done by Mahmoud et al., MPI and
TFPV conﬁrm the classic measurements of pulsed-wave Dopp-
ler LV inﬂow and suggest an early stage of LV diastolic dys-
function in the course of the disease [19].
Aim of the work
This study was undertaken to evaluate ventricular function in
young adults with bronchial asthma.
Subjects and methods
Fifty young adult patients with bronchial asthma were in-
cluded in this study. All asthmatic patients had paroxysmal at-
tacks of wheezy chest, dyspnea, cough and expectoration or
documented reversible airway obstruction as determined by a
20% improvement in FEV1 after bronchodilator administra-
tion or peak expiratory ﬂow rate variability (>20%). All pa-
tients were attendant or came for follow up in chest
outpatient clinics of Al-Hayah National Hospital, Khames
Mushyt, Kingdom of Saudi Arabia during the period from
January to December 2011. The study protocol was approved
by the local ethics committee. Informed consent was obtained
from the patients.
Inclusion criteria include all patients met the criteria for
bronchial asthma [20] in the age group of 18–40 years old from
both genders. Exclusion criteria include patients with bron-
chial asthma outside the age range or with respiratory tract
infections, diabetes mellitus, systemic hypertension, congenital
cardiac malformation, arrhythmia, heart failure or valvular
heart disease. We exclude patients above the age of 40 to avoid
the effect of age on the diastolic function.
Fifty patients with bronchial asthma and 30 control sub-
jects participated in this study. Twenty-three patients were
males and 27 patients were females. The age of the patients
ranged from 18 to 38 years, with a mean age ±SD of
28.3 ± 7.0 years. In all patients asthma was controlled or par-
tially controlled on medication (inhaled corticosteroids and
long acting b2 agonists) [20]. The 30 healthy volunteers in-
cluded 13 males and 17 females, with an age range from 18
to 36 years with a mean age of 26.8 ± 6.2 years. All healthy
subjects had no history of rhinitis, eczema, or spontaneous
wheezing, and were not receiving any medications.
Echocardiographic evaluation of ventricular function 29All patients were subjected to the following: thorough med-
ical history and clinical examination. Chest radiological exam-
ination, Ventilatory function tests, spirometry was performed
using ‘‘Spirosift spirometry 5000 FUKUDA DENSHI’’,
ECG, CBC, ESR, renal function and liver function were done
for all patients. Conventional echocardiographic study avail-
able in our hospital was performed using a Philips HD11XE
machine (Philips, Inc., USA) with 2–4 MHz phased array
transducer and a color-coded Doppler screen. Real time 2D,
M-mode, colored and Doppler study was done for all cases
with simultaneous ECG recording. Spectral Doppler tracings
were recorded. All cardiac dimensions including IVS, LVPW,
LV systolic and diastolic dimensions and left atrial and aortic
root dimensions were measured [21]. Pulsed Doppler record-
ings of ventricular inﬂow, by placing the sample volume at
the tips of the mitral and tricuspid leaﬂets. MPI was measured
as the sum of isovolumetric contraction and isovolumetric
relaxation time divided by the LV ejection time. From pulsed
Doppler spectrum of the ventricular inﬂow, the time interval
‘‘a’’ calculated from the cessation to the onset of ventricular in-
ﬂow was considered as the sum of isovolumetric relaxation
time. The ventricular ejection time ‘‘b’’ was the duration of
ventricular outﬂow velocity proﬁle. MPI can be calculated eas-
ily by a simple formula: (a  b)/b [22]. The isovolumetric relax-
ation time, isovolumetric contraction time, peak E velocity,
peak A velocity and the deceleration time of the E wave were
also measured. TFPV was obtained by color Doppler M-mode
echocardiography from the apical four chamber view as de-
scribed by Garcia et al. [18].
Statistical analyses
Statistical analysis of the present study was conducted, using
SPSS V.16. To compare two independent samples we used
an unpaired t-test. A p-value <0.05 was considered signiﬁcant.
Results
The demographic and clinical features of the bronchial asthma
and control groups are given in Table 1. There were no statis-
tically signiﬁcant differences in age, weight, heart rate, systolic
and diastolic blood pressures between bronchial asthma pa-
tients and controls.
Table 2 shows that there were no statistically signiﬁcant dif-
ferences in the echocardiographic indices of RV dimensions
and functions between the two groups.Table 1 Characteristics of study subjects.
BA group
Age (years) 28.3 ± 7.
Sex (male/female) 23/27
Height (cm) 173.8 ± 1
Weight (kg) 68.15 ± 3
Respiratory rate (cycle/min) 15.16 ± 1
Heart rate (beats/min) 84.21 ± 3
Systolic BP (mm Hg) 123.78 ±
Diastolic BP (mm Hg) 81.45 ± 3
p> 0.05 for all of the above variables.Table 3 shows echocardiographic parameters of LV func-
tions. There were statistically signiﬁcant differences in the peak
E velocity, peak E velocity/peak A velocity ratio, isovolumetric
relaxation time, myocardial performance index (MPI) and
TFPV between the two groups (p< 0.05). On the other hand,
there were no statistically signiﬁcant differences in the mean
value of peak A velocity, deceleration time, isovolumetric con-
traction time, ejection time and E velocity/TFPV between BA
and control groups.
Discussion
Bronchial asthma (BA) is a common chronic inﬂammatory
condition affecting the airways. Bronchial asthma not only af-
fects the lung but also affects other organs including the heart.
Even with mild cases, subclinical cardiac dysfunction can be
documented and the severity of cardiac affection is parallel
to the severity of the disease. LV diastolic dysfunction was ob-
served in severe BA. The occurrence of supraventricular tachy-
cardia in BA is related to the presence of interventricular septal
hypertrophy, LV dysfunction, and increased PAP [8]. Tissue
Doppler Echocardiography was found to be more sensitive
in detecting cardiac dysfunction than conventional Doppler.
However, these cardiac dysfunctions may be reversible espe-
cially in acute cases [5,6].
In the present study it was found that both groups (asthma
patients and controls) were properly matched together regard-
ing age/years (28.3 ± 7.0 and 26.8 ± 6.2, respectively, p-value
>0.05), height/cm (173.8 ± 19.5 and 168.5 ± 15.9, respec-
tively, p-value >0.05) and weight/kg (68.15 ± 3.99 and
66.35 ± 3.36, respectively, p-value >0.05). Also there were
no statistically signiﬁcant differences in respiratory rate, heart
rate, systolic and diastolic blood pressures between bronchial
asthma patients and controls. This ﬁnding is corresponding
to the study done by Shedeed; who found that there were no
statistically signiﬁcant differences between asthmatic children
and controls regarding heart rate, systolic and diastolic blood
pressure [23]. Also Mahmoud et al.; found the same results
[19].
In this study there were no signiﬁcant differences in the
echocardiographic indices of RV dimensions and functions be-
tween the two groups (RV wall thickness, RV diameter, E
velocity, A velocity, E/A velocity ratio, isovolumetric relaxa-
tion time, isovolumetric contraction time and ejection time).
Also the mean RV MPI in the bronchial asthma group
(0.29 ± 0.11) was not signiﬁcantly different from that of the(n= 50) Control group (n= 30)
0 26.8 ± 6.2
13/17
9.5 168.5 ± 15.9
.99 66.35 ± 3.36
.36 14.8 ± 1.06
.52 81.46 ± 2.6
2.95 116.13 ± 3.44
.11 79.33 ± 3.02
Table 2 Echocardiographic parameters of RV functions.
BA group (n= 50) Control group (n= 30)
RV wall thickness (cm) 1.27 ± 0.68 1.04 ± 0.52
RV diameter (cm) 2.16 ± 0.72 1.96 ± 0.67
E velocity (cm/s) 66.28 ± 11.52 70.93 ± 12.45
A velocity (cm/s) 40.21 ± 11.74 37.53 ± 10.91
E/A velocity ratio 1.54 ± 0.11 1.76 ± 0.18
Isovolumetric relaxation time (ms) 39.54 ± 2.50 43.83 ± 2.69
Isovolumetric contraction time (ms) 37.12 ± 2.37 38.03 ± 2.67
Ejection time (ms) 285.30 ± 7.64 292.50 ± 6.54
Myocardial performance index (MPI) 0.29 ± 0.11 0.27 ± 0.08
p> 0.05 for all of the above variables.
Table 3 Echocardiographic parameters of LV functions.
BA group (n= 50) Control group (n= 30)
E velocity (cm/s) 55.74 ± 6.31* 76.56 ± 3.94
A velocity (cm/s) 67.88 ± 4.43 65.30 ± 4.17
E/A velocity ratio 0.9 ± 0.7* 1.3 ± 0.5
Isovolumetric relaxation time (ms) 73.68 ± 5.29* 56.50 ± 8.08
Deceleration time (ms) 164.78 ± 16.88 144.40 ± 16.07
Isovolumetric contraction time (ms) 35.74 ± 4.12 37.93 ± 4.84
Ejection time (ms) 267.34 ± 16.15 276.83 ± 12.75
Myocardial performance index (MPI) 0.40 ± 0.13* 0.36 ± 0.11
TFPV (cm/s) 37.10 ± 2.13* 43.40 ± 3.11
E velocity/TFPV 1.9 ± 0.9 1.7 ± 0.8
TFPV, transmitral ﬂow propagation velocity.
* p< 0.05.
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ously published normal values (0.28 ± 0.04) [24]. This was in
agreement with Mahmoud et al. [19] who observed no signiﬁ-
cant difference in the echocardiographic indices of RV perfor-
mance between the two groups, Elmasry et al. [25] who
revealed that the right ventricular echocardiographic dimen-
sions showed no signiﬁcant differences among asthmatic pa-
tients compared to control subjects and Alpaslan et al. [26]
and was in disagreement with Chicherina et al. [8] who con-
cluded that diastolic dysfunction of the right ventricle was
the earliest hemodynamic changes in bronchial asthma. Also
Eniseeva et al. [27] reported that in patients with bronchial
asthma, the degree of right ventricular dysfunction depends
on right ventricular hypertrophy and total pulmonary resis-
tance. This could be explained by the younger age of our study
group and the well controlled asthma in our patients so that;
the clinical and echocardiographic ﬁndings of chronic lung dis-
eases are not signiﬁcant.
In our study we found that there were statistically signiﬁ-
cant differences between the bronchial asthma group and the
control group regarding the peak E velocity (55.74 ± 6.31
and 76.56 ± 3.94, respectively, p-value <0.05), peak E veloc-
ity/peak A velocity ratio (0.9 ± 0.7 and 1.3 ± 0.5, respec-
tively, p-value <0.05), isovolumetric relaxation time
(73.68 ± 5.29 and 56.50 ± 8.08, respectively, p-value <0.05),
myocardial performance index (MPI) (0.40 ± 0.13 and
0.36 ± 0.11, respectively, p-value <0.05) and TFPV
(37.10 ± 2.13 and 43.40 ± 3.11, respectively, p-value <0.05).
These ﬁndings are corresponding to the study done by Mah-moud et al. [19] who evaluated ventricular function by mea-
surement of myocardial performance index (MPI) and
transmitral ﬂow propagation velocity (TFPV) in patient with
bronchial asthma and found that the peak E velocity, E veloc-
ity/A velocity ratio, isovolumetric relaxation time, MPI and
TFPV in the BA group were signiﬁcantly different from those
of the controls (p< 0.05). They also concluded that; LV dia-
stolic function is impaired in patients with bronchial asthma.
Also Hirono et al. [28] studied LV diastolic dysfunction in pa-
tients with bronchial asthma with long term oral b2-adreno-
ceptor agonists and found that the regular use of oral b2-
adrenoceptor agonists induced left ventricular diastolic dys-
function. Goloskokova et al. [29] studied right and left ventric-
ular functions in patients with asthma and found that LV
alterations in patients with asthma were minimal and included
LV diastolic dysfunction in patients with severe asthma. These
alterations deteriorated as asthma step increased. Elmasry
et al. [25] assessed the left ventricular function among asth-
matic children both during and after resolution of acute severe
asthma and found that during acute exacerbations of asthma,
patients had signiﬁcantly higher transmitral peak A velocity
and lower E/A ratio (i.e. impaired LV diastolic function) dur-
ing acute asthma exacerbation but disappeared after its resolu-
tion and concluded that transmitral inﬂow velocity patterns
during acute severe asthma in children are suggestive of altered
LV preload due to an acute transient elevation in pulmonary
artery pressure secondary to the altered lung mechanics.
Several mechanisms may be responsible for diastolic dys-
function in bronchial asthma. The ﬁrst and most important
Echocardiographic evaluation of ventricular function 31factor is the signiﬁcantly increased heart rate in the bronchial
asthma group. Tachycardia shortened the diastolic ﬁlling per-
iod and atrial contraction may have occurred before the early
ﬁlling was completed; the myocardial performance index will
be higher than it would be if the heart rate was slower. This
tachycardia may be due to multiple causes including hypox-
emia or medications (Mahmoud et al. [19]). Hirono et al.
[28] concluded that Long-term use of oral b2 agonists impaired
left ventricular diastolic function in patients with BA, and the
cessation of b2 agonists reversed diastolic pump performance
to the normal level.
Conclusion
From this study we concluded that LV diastolic function is im-
paired in patients with bronchial asthma despite no effect on
RV diastolic function.
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